2016 American Transplant Congress
Long-Term Efficacy and Safety of Everolimus Based Immunosuppression on De Novo Kidney Transplantation with 7 Years Follow-Up.
Purpose: Long-term efficacy and safety of everolimus (EVR) based immunosuppression for de novo kidney transplant recipient who were involved in A1202 study from our institute…2016 American Transplant Congress
Steroid Free Immunosuppression and Clinical Outcomes in Recipients of Deceased Donor Kidney Transplant with Positive Flow Cytometry Crossmatch.
Indiana University, Indianapolis.
Background: Positive flow cytometry crossmatch (FCXM) is considered a high immunologic risk for transplantation. Available studies reporting outcomes in positive FCXM kidney transplants were done…2016 American Transplant Congress
Impact of Transfusion Requirements on Likelihood of Heart Transplantation After Total Artificial Heart.
Background:Total artificial heart (TAH) is used as a bridge to heart transplantation in patients with end-stage biventricular failure. Anemia requiring blood transfusions occurs following TAH…2016 American Transplant Congress
Liver Evaluation for Heart Transplantation: Which Is Better, Noninvasive Scans or Liver Biopsy?
Cedars-Sinai Heart Institute, Los Angeles, CA.
Background: Patients awaiting heart transplantation who have known liver disease from congestive hepatopathy are at increased risk for mortality post-transplantation. The evaluation of the liver…2016 American Transplant Congress
Liver Recipient with Renal Dysfunction: Liver Only or Simultaneous Liver-Kidney Transplant?
University of Minnesota, Minneapolis, MN.
Background: The OPTN listing criteria for Simultaneous liver-kidney transplant (SLK) are not well defined. There are concerns about rising numbers of SLKs, which take kidneys…2016 American Transplant Congress
Inferior Outcomes in Hepatitis C Virus Positive Donors to Hepatitis C Virus Negative Kidney Recipients: Analysis of National Data.
Virginia Commonwealth University, Richmond, VA.
Background: Kidney transplantation (KTxp)with HCV kidneys (HCV D+)may represent a safe resource to expand the donor pool, and to reduce waiting time in patients with…2016 American Transplant Congress
Pre-Transplant Coronary Artery Disease: An Underestimated Risk Factor for Post-Transplant Mortality?
Nephrology, Charite Universitaetsmedizin, Berlin, Germany.
Background: Coronary artery disease is a frequent comorbidity among transplant candidates. Limited data exist on the long-term outcomes of kidney transplant recipients (KTR) with pre-existing…2016 American Transplant Congress
Steroid Use May Not Increase Risk of Fracture in Kidney Transplant Patients.
Introduction: Chronic steroid use is associated with bone mineral loss, and osteoporosis. However, it is not clear if chronic steroid use in post-kidney transplant patients…2016 American Transplant Congress
Defining Frailty in Liver Transplant Recipients.
PURPOSETo define frailty in the liver transplant (OLT) population to optimize care and assist in predicting post OLT outcomes.METHODSAll adult primary OLT patients from 01/2010…2016 American Transplant Congress
Hematopoietic Progenitor Cells and Monocyte Subsets and Hepatic Decompensation in Patients Referred for Liver Transplant Evaluation.
Background: Abnormal hepatic and systemic angiogenesis is an important component of advanced liver disease. Circulating hematopoietic progenitor cells (HPCs) and M2 monocytes are thought to…
- « Previous Page
- 1
- …
- 115
- 116
- 117
- 118
- 119
- …
- 180
- Next Page »